Workshop On

End-to-End Analytical Solutions for mRNA Therapeutics 

Supporting Manufacturing and CMC Needs

April 14–15, 2026  | ROCKVILLE, MD

Co-Hosted By:

About The Event 

Join leading scientists, industry experts, and regulatory stakeholders for a two-day in-person workshop on End-to-End Analytical Solutions for mRNA Therapeutics: Supporting Manufacturing and CMC Needs, focused on advancing analytical strategies for mRNA therapeutics.

Explore critical aspects of Chemistry, Manufacturing, and Controls (CMC) for mRNA-based products, with sessions dedicated to raw material qualification, innovative analytical methods, platform technologies, and emerging applications such as cancer vaccines and gene therapies.

This workshop is ideal for professionals involved in mRNA development, manufacturing, and regulatory affairs who are seeking to deepen their understanding of analytical requirements and platform strategies in this rapidly evolving field.

The agenda will include presentations and discussions on:

  • Raw material qualification
  • New and improved analytical methods for CQA assessment
  • Leveraging manufacturing and analytical platforms to support mRNA therapeutics
  • Correlation between physical and functional characteristics of mRNA products
  • Use of mRNA in different modalities, including cell and gene therapies, cancer vaccines, and other new applications

Speakers

Albert Kamanzi, ph.D.

ScopeSys Inc.

CLiC analytical platform for the multi-parametric characterization of mRNA–LNP therapeutics 

Kala Dasuri, PH.D

Sanofi

Platform-Based Analytical Strategies to Accelerate mRNA-LNP Product Development: Applicability and Case Studies

Mark Lowenthal, ph.D.

National Institute of Standards and Technology

Comparability of analytical techniques that assess mRNA drug-substance CQAs: NIST RGTM 10202 FLuc mRNA

Martin Gilar, Ph.D.

Waters Corporation

Advances in mRNA analysis with liquid chromatography methods

Matt Ranaghan, PH.D.

Refeyn

Mass Photometry as a Multiple-Attribute Tool for mRNA Therapeutic Development   

Mohamad Toutounji, Ph.D.

Molgenium

A Novel RIG I Based Assay for Quantitative Detection of dsRNA Contaminants in RNA therapeutics

Sixuan Li

Johns Hopkins University

Messenger RNA and Guide RNA Distributions in Lipid Nanoparticles Impact Gene Editing Efficiency In Vivo: A framework for RNA LNP rational design guided by single-particle attributes  

Sonia Taktak, Ph.D., MBA

Pfizer

DNA starting material control strategy 

Wayne Doyle, PH.D

Eclipsebio

Integrating Sequencing Analytics into mRNA Manufacturing and Quality Control

Mohamad Toutounji, Ph.D.

Molgenium

A Novel RIF I Based Assay for Quantitative Detection of dsRNA Contaminants in RNA therapeutics

Sonia Taktak, Ph.D., MBA

Pfizer

DNA starting material control strategy 

Sixuan Li

Johns Hopkins University

Messenger RNA and Guide RNA Distributions in Lipid Nanoparticles Impact Gene Editing Efficiency In Vivo: A framework for RNA LNP rational design guided by single-particle attributes  

The full line up of speakers will be available soon!

Why Attend? 

Hear scientific presentations on cutting-edge analytical methods and CQA assessment

Gain insights into the correlation between physical and functional characteristics of mRNA products

Explore applications of mRNA across diverse therapeutic modalities

Contribute as a speaker through abstract submission